In addition, the growing integration of advanced diabetes technologies, and artificial intelligence (AI), into the management of T1D presents considerable potential for improving glycemic control through decision support systems that optimize automated insulin therapy [41]. The gene discussed is INS; the disease is type 1 diabetes mellitus.